Curocell (XKRX:372320) General and Admin. Expense : ₩ Mil (TTM As of Jun. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Curocell General and Admin. Expense?

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. Curocell's General and Admin. Expense for the six months ended in Jun. 2023 was ₩213.46 Mil. Curocell does not have enough years/quarters to calculate the General and Admin. Expense for the trailing twelve months (TTM) ended in Jun. 2023.

Curocell General and Admin. Expense Historical Data

The historical data trend for Curocell's General and Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curocell General and Admin. Expense Chart

Curocell Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

General and Admin. Expense

63.10

47.36

41.51

165.01

425.26

Curocell Semi-Annual Data
	Jun22	Dec22	Jun23	Dec23
General and Admin. Expense	80.27	84.74	213.46	211.80

Curocell General and Admin. Expense Calculation

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.

Curocell General and Admin. Expense Related Terms

Thank you for viewing the detailed overview of Curocell's General and Admin. Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Curocell (XKRX:372320) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Curocell Inc (XKRX:372320) » Definitions » General and Admin. Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

11, Gukjegwahak 16-ro, Yuseong-gu, Daejeon, KOR, 34002

Website

https://www.curocellbtx.com

Curocell Inc is engaged in medical and pharmaceutical research and development. The company is into development of CAR-T treatments that enhance the natural function of immune cells to eliminate cancer cells through genetic manipulation of human immune cells.

Curocell (XKRX:372320) Headlines

No Headlines